The hemagglutinin stalk is relatively conserved compared to the highly variable head region. This conservation makes it an attractive target for developing universal influenza vaccines. The idea is that a vaccine targeting the stalk could provide broader and longer-lasting protection against multiple influenza strains. Traditional vaccines focus on the head of hemagglutinin, which frequently mutates, necessitating annual updates to the vaccine formulation.
